Shares of ResMed Inc. RMD rallied 1.61% to $237.13 Thursday, on what proved to be an all-around poor trading session for the ...

The broker is feeling very bullish about the sleep disorder treatment company. The post Goldman Sachs tips ResMed shares to ...

Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...

Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.

Signal Advisors Wealth LLC increased its stake in ResMed Inc. (NYSE:RMD – Free Report) by 6.1% in the 4th quarter, according ...

Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...

Shares of ResMed Inc. (NYSE:RMD – Get Free Report) have earned a consensus rating of “Hold” from the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst ...

Goldman Sachs has initiated coverage on medical equipment maker ResMed and biotech giant CSL with a ‘buy’ ratings as analysts ...

Over the past year, many ResMed Inc. (NYSE:RMD) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually more ...

Chipotle Mexican Grill owns and operates Chipotle Mexican Grill restaurants. The company’s expected earnings growth rate for ...

The stock's rise snapped a four-day losing streak.